In a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies, and its wholly owned subsidiary Sequent Research with it.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
